Native Human Leucine-rich Alpha 2 Glycoprotein-1 (LRG1) protein
Beta LifeScience
SKU/CAT #: BAR-0114P
Native Human Leucine-rich Alpha 2 Glycoprotein-1 (LRG1) protein
Beta LifeScience
SKU/CAT #: BAR-0114P
Regular price$82500
$825.00
/
Submit an inquiry or email sales for a custom bulk quote. Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
| Description | In normal plasma LRG1 has a concentration of 21-50 ug/ml. It is an acute phase protein with levels elevated in patients with bacterial infections; interestingly, during the inflammatory response, LRG1 levels are not correlated with CRP levels. LRG1 binds cytochrome c, an initiator/amplifier of programmed cell death (apoptosis), and by binding cytochrome c, is thought to play a role in cell survival. LRG1 is a biomarker associated with several cancers, including non-small cell lung cancer, colorectal cancer, and pancreatic cancer. Recent studies have shown it is three-fold more abundant in ovarian cancer serum compared to non-cancer control serum. LRG1 levels are only moderately correlated with CA125 levels. Elevated levels of LRG1 in cerebral spinal fluid are being studied as markers for the early diagnosis of Parkinson's disease and progressive supranuclear palsy. |
| Source | Human Plasma |
| Form | Lyophilized Powder |
| Buffer | Lyophilized from 20 mM Tris, 20 mM NaCl, pH 7.5 |
| Purity | Greater than 95% as determined by SDS-PAGE. Positive reaction to anti-LRG1 on Western Blot. |
| Molecular Weight | 50 kDa |
| Protein Determination | Extinction Coefficient (E) = 0.70 (0.1% at 280 nm, 1 cm pathway) |
| Storage/Handling | ≤ -20°C |

